-
Something wrong with this record ?
Citrulline activates adenosine receptors: New insight into metabolic pathways interaction
A. Soloviev, V. Kozlowsky, V. Sydorenko, I. Ivanova, D. Samofalova, V. Fetyukhin
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Pulmonary Artery drug effects metabolism MeSH
- Citrulline * pharmacology metabolism MeSH
- Rats MeSH
- Rats, Wistar MeSH
- Receptors, Purinergic P1 metabolism MeSH
- Molecular Docking Simulation * MeSH
- Muscle, Smooth, Vascular metabolism drug effects MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Citrulline is a non-proteinogenic amino acid that forms as by-product in nitric oxide (NO) synthesis from arginine and may act in concert with NO as an independent signaling molecule that involves in the mechanism of vascular smooth muscle vasodilation. In this study we examined the effects of citrulline on pulmonary artery smooth muscles. Experimental design comprised outward potassium currents measurements in enzymatically isolated rat pulmonary artery smooth muscle (PASMc) cells using whole-cell patch clamp technique, isometric contractile force recordings on rat pulmonary artery rings and method of molecular docking simulation. Citrulline in a concentration 10-9-10-5 M relaxed phenylephrine (PHE)-preactivated SM of rat pulmonary artery in a dose-dependent manner (EC50 0,67 μM). This citrulline-induced relaxation was dependent on an intact endothelium. Bath application of citrulline (10-8-10-5 M) on isolated PASMc induced a significant increase in the amplitude of outward potassium current (Ik). The adenosine antagonist caffeine (10-6 M) effectively blocked both the citrulline-induced relaxation response and Ik increment. Molecular docking modeling suggests that caffeine blocking the potent activity of citrulline results from competitive interactions at the A2 adenosine receptor binding site. In summary, our data suggest that citrulline, released with NO at low concentrations, can effectively interact with adenosine receptors in smooth muscle cells, causing their relaxation, indicating surprising interaction between NO and adenosine pathways.
1 F Lab LLC Life Chemicals Inc distributor Kyiv 02094 Ukraine
Institute of Pharmacology and Toxicology National Academy of Medical Sciences Kyiv 03057 Ukraine
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003706
- 003
- CZ-PrNML
- 005
- 20250206104630.0
- 007
- ta
- 008
- 250121e20240803enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2024.116462 $2 doi
- 035 __
- $a (PubMed)39102990
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Soloviev, Anatoly $u Institute of Pharmacology and Toxicology, National Academy of Medical Sciences, Kyiv 03057 Ukraine. Electronic address: a.soloviev@ift.org.ua
- 245 10
- $a Citrulline activates adenosine receptors: New insight into metabolic pathways interaction / $c A. Soloviev, V. Kozlowsky, V. Sydorenko, I. Ivanova, D. Samofalova, V. Fetyukhin
- 520 9_
- $a Citrulline is a non-proteinogenic amino acid that forms as by-product in nitric oxide (NO) synthesis from arginine and may act in concert with NO as an independent signaling molecule that involves in the mechanism of vascular smooth muscle vasodilation. In this study we examined the effects of citrulline on pulmonary artery smooth muscles. Experimental design comprised outward potassium currents measurements in enzymatically isolated rat pulmonary artery smooth muscle (PASMc) cells using whole-cell patch clamp technique, isometric contractile force recordings on rat pulmonary artery rings and method of molecular docking simulation. Citrulline in a concentration 10-9-10-5 M relaxed phenylephrine (PHE)-preactivated SM of rat pulmonary artery in a dose-dependent manner (EC50 0,67 μM). This citrulline-induced relaxation was dependent on an intact endothelium. Bath application of citrulline (10-8-10-5 M) on isolated PASMc induced a significant increase in the amplitude of outward potassium current (Ik). The adenosine antagonist caffeine (10-6 M) effectively blocked both the citrulline-induced relaxation response and Ik increment. Molecular docking modeling suggests that caffeine blocking the potent activity of citrulline results from competitive interactions at the A2 adenosine receptor binding site. In summary, our data suggest that citrulline, released with NO at low concentrations, can effectively interact with adenosine receptors in smooth muscle cells, causing their relaxation, indicating surprising interaction between NO and adenosine pathways.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a citrulin $x farmakologie $x metabolismus $7 D002956
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a arteria pulmonalis $x účinky léků $x metabolismus $7 D011651
- 650 _2
- $a svaly hladké cévní $x metabolismus $x účinky léků $7 D009131
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a purinergní receptory P1 $x metabolismus $7 D018047
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kozlowsky, Vadym $u LLC "MEDIVALEX", Praha 15200, Czech Republic
- 700 1_
- $a Sydorenko, Vadym $u Institute of Pharmacology and Toxicology, National Academy of Medical Sciences, Kyiv 03057 Ukraine
- 700 1_
- $a Ivanova, Irina $u Institute of Pharmacology and Toxicology, National Academy of Medical Sciences, Kyiv 03057 Ukraine
- 700 1_
- $a Samofalova, Dariia $u I.F. Lab, LLC, Life Chemicals Inc. distributor, Kyiv 02094 Ukraine
- 700 1_
- $a Fetyukhin, Vladimir $u I.F. Lab, LLC, Life Chemicals Inc. distributor, Kyiv 02094 Ukraine
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 229 (20240803), s. 116462
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39102990 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104625 $b ABA008
- 999 __
- $a ok $b bmc $g 2263460 $s 1239713
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 229 $c - $d 116462 $e 20240803 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $a Pubmed-20250121